Designed for Ultimate Flexibility and Robust Antibody StainingThe intelliPATH+ has been meticulously redesigned with input from users and the latest techno...
Medicine and hospitals are increasingly becoming digital and technological. After the Covid-19 pandemic, virtual consultations, online appointment ...
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...
Approved by both FDA and Health Canada, MADM™ easily connects to any ventilator to safely and accurately enable gas anesthesia. The lightweight and c...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has filed for orphan ...
A wave of respiratory illnesses, accompanied by alarming clusters of pneumonia cases, has inundated hospitals in northern China, sparking deep concerns abo...
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...
With a steadfast dedication of 22 years to advancing the fundamental technologies of raw materials, reagent and instrument, Fapon strives to empower the gl...
CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic Neuraceq® (florbetaben 18F injection) has ...
GE HealthCare (Nasdaq: GEHC) has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, the first remote pat...
Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...
“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exacte...
TBI is an urgent and prominent public health challenge, impacting millions each year as a result of head trauma from accidents, falls, sports-related incid...
Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology Medtronic plc (NYSE: MDT), a ...
© 2025 Biopharma Boardroom. All Rights Reserved.
